Sarantis Worldwide


Visit our group site

Sarantis Group| English

Or choose a location

INVESTOR'S PRESS

IR Releases

30 OCTOBER 2023

Purchase of own shares

GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 27th 2023 with the purchase of 9,807 own shares at the average price of 7.

30 OCTOBER 2023

Release of Regulated Information : Transactions Notification

The company GR. SARANTIS S.A. announces, according to L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, the following: Grigoris Sarantis (Chairman of the Board of Directors and Executive Member) proceeded on October 25th of 2023 with the purchase of 3,915 common shares in total at the average price of 7.

27 OCTOBER 2023

Purchase of own shares

GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 26th 2023 with the purchase of 7,716 own shares at the average price of 7.

26 OCTOBER 2023

Purchase of own shares

GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 25th 2023 with the purchase of 1,400 own shares at the average price of 7.

25 OCTOBER 2023

Purchase of own shares

GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 24th 2023 with the purchase of 8,152 own shares at the average price of 7.

25 OCTOBER 2023

Release of Regulated Information : Transactions Notification

The company GR. SARANTIS S.A. announces, according to L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, the following: Kyriakos Sarantis, CEO of the Group and Executive Member of the company’s BoD, proceeded on October 20th of 2023 with the purchase of 114,134 common shares in total at the average price of 7.

24 OCTOBER 2023

Sarantis Group: 10 Awards at the Best in Pharmacy Awards 2023

Sarantis Group achieved great success at the Best in Pharmacy Awards 2023, winning a total of 10 awards that highlight its dedication to excellence and innovation in the pharmaceutical industry. The Best in Pharmacy Awards 2023 were, once again, organized in Greeece by BOUSSIAS events, providing an opportunity for companies, products, marketing practices and services that stand out in the pharmacy sector to be recognized and enjoy the recognition they deserve.

24 OCTOBER 2023

Purchase of own shares

GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on October 23rd 2023 with the purchase of 2,544 own shares at the average price of 7.

Press Releases

Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!

More
Change cookies consent Revoke cookies consent